Skip to main content
Top
Published in: International Cancer Conference Journal 1/2018

01-01-2018 | Case report

Pericardial effusion-induced subcutaneous edema in the trunk and lower limbs after percutaneous drainage for carcinomatous pericarditis: report of a case

Authors: Yoichi Nakamura, Junya Tokuhisa, Koji Asai, Toshiyuki Enomoto, Manabu Watanabe, Yoshinari Enomoto, Yoshinori Kikuchi, Yoshihisa Saida, Hideaki Shimada, Shinya Kusachi

Published in: International Cancer Conference Journal | Issue 1/2018

Login to get access

Abstract

The recurrence of gastric cancer is rarely associated with cardiac tamponade induced by carcinomatous pericarditis. We encountered a patient in whom cancer recurred as carcinomatous pericarditis 9 years after surgery for advanced gastric cancer. Furthermore, pericardial effusion caused marked subcutaneous edema in her trunk and lower limbs after percutaneous pericardial drainage was applied to treat cardiac tamponade. A 49-year-old woman presented with lower limb edema and exertional dyspnea 9 years after distal gastrectomy for advanced gastric cancer. Chest computed tomography and ultrasonography showed bilateral pleural effusion and pericardial effusion. Pericardial drainage and thoracocentesis were performed, and her symptoms of respiratory distress remitted. Class V adenocarcinoma was detected on cytology from both effusions, and was diagnosed as the recurrence of gastric cancer. After systemic chemotherapy, she was admitted for the aggravation of dyspnea because of recurrent retention of pericardial effusion. Pericardiocentesis was repeated. The pericardial effusion became subcutaneously retained in the trunk below the puncture site over the lower limbs via the drainage route. Edema in the trunk below the abdomen and lower limbs gradually aggravated over time. The skin extended and became sclerotic because of severe edema, liquid leaked from abdominal skin injuries, and the condition became similar to skin lymphorrhea in lymphedema. Neoplastic cardiac tamponade due to gastric cancer has an extremely low incidence and a poor prognosis. We encountered a patient in whom pericardial effusion caused subcutaneous edema in the trunk and lower limbs after percutaneous pericardial drainage was applied to treat carcinomatous pericarditis associated with gastric cancer.
Literature
1.
go back to reference Vaitkus PT, Herrmann HC, LeWinter MM (1994) Treatment of malignant pericardial effusion. JAMA 272:59–64CrossRefPubMed Vaitkus PT, Herrmann HC, LeWinter MM (1994) Treatment of malignant pericardial effusion. JAMA 272:59–64CrossRefPubMed
2.
go back to reference Buck M, Ingle JN, Guiliani ER et al (1987) Pericardial effusion in women with breat cancer. Cancer 60:263–269CrossRefPubMed Buck M, Ingle JN, Guiliani ER et al (1987) Pericardial effusion in women with breat cancer. Cancer 60:263–269CrossRefPubMed
4.
go back to reference Takayama T, Okura Y, Okada Y et al (2015) Characteristics of neoplastic cardiac tamponade and prognosis after pericardiocentesis: a single-center study of 113 consecutive cancer patients. Int J Clin Oncol 20:872–877CrossRefPubMed Takayama T, Okura Y, Okada Y et al (2015) Characteristics of neoplastic cardiac tamponade and prognosis after pericardiocentesis: a single-center study of 113 consecutive cancer patients. Int J Clin Oncol 20:872–877CrossRefPubMed
5.
go back to reference Adler Y, Charron P, Imazio M et al (2015) 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. Eur Heart J 36:2921–2964CrossRefPubMed Adler Y, Charron P, Imazio M et al (2015) 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. Eur Heart J 36:2921–2964CrossRefPubMed
6.
go back to reference Kobayashi M, Okabayashi T, Okamoto K et al (2005) Clinicopathological study of cardiac tamponade due to pericardial metastasis originating from gastric cancer. World J Gastroenterol 11:6899–6904CrossRefPubMedPubMedCentral Kobayashi M, Okabayashi T, Okamoto K et al (2005) Clinicopathological study of cardiac tamponade due to pericardial metastasis originating from gastric cancer. World J Gastroenterol 11:6899–6904CrossRefPubMedPubMedCentral
7.
go back to reference Varvarigos N, Kamaradou H, Kourti A et al (2001) Cardiac tamponade as the first manifestation of gastric cancer and remission after chemotherapy. Dig Dis Sci 46:2333–2335CrossRefPubMed Varvarigos N, Kamaradou H, Kourti A et al (2001) Cardiac tamponade as the first manifestation of gastric cancer and remission after chemotherapy. Dig Dis Sci 46:2333–2335CrossRefPubMed
8.
go back to reference Kusaba H, Fujihara M, Nagashima R et al (2008) Systemic chemotherapy of TS-1 and cisplatin for gastric signet-ring cell carcinoma presenting as cardiac tamponade. Med Oncol 25:241–244CrossRefPubMed Kusaba H, Fujihara M, Nagashima R et al (2008) Systemic chemotherapy of TS-1 and cisplatin for gastric signet-ring cell carcinoma presenting as cardiac tamponade. Med Oncol 25:241–244CrossRefPubMed
9.
go back to reference Zhang BL, Xu RL, Zheng X, Qin YW (2010) A case with cardiac tamponade as the first sign of primary gastric signet-ring cell carcinoma treated with combination therapy. Med Sci Mon Int Med J Exp Clin Res 16:CS41-44 Zhang BL, Xu RL, Zheng X, Qin YW (2010) A case with cardiac tamponade as the first sign of primary gastric signet-ring cell carcinoma treated with combination therapy. Med Sci Mon Int Med J Exp Clin Res 16:CS41-44
10.
go back to reference Kuga Y, Okanobu H, Kitamura S et al (2013) A case of advanced gastric cancer with carcinomatous pericarditis effectively treated by S-1/CDDP combined therapy (in Japanese with English abstract). Jpn J Cancer Chemother 40:87–89 Kuga Y, Okanobu H, Kitamura S et al (2013) A case of advanced gastric cancer with carcinomatous pericarditis effectively treated by S-1/CDDP combined therapy (in Japanese with English abstract). Jpn J Cancer Chemother 40:87–89
11.
go back to reference Arisoy A, Memic K, Karavelioglu Y, Sen F (2014) Cardiac tamponade as the first clinical sign of gastric adenocarcinoma: a rare condition. Turk Kardiyol Der Ars 42:377–379CrossRef Arisoy A, Memic K, Karavelioglu Y, Sen F (2014) Cardiac tamponade as the first clinical sign of gastric adenocarcinoma: a rare condition. Turk Kardiyol Der Ars 42:377–379CrossRef
12.
go back to reference Tsang TS, Seward JB, Barnes ME et al (2000) Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy. Mayo Clin Proc 75:248–253CrossRefPubMed Tsang TS, Seward JB, Barnes ME et al (2000) Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy. Mayo Clin Proc 75:248–253CrossRefPubMed
13.
go back to reference Saltzman AJ, Paz YE, Rene AG et al (2012) Comparison of surgical pericardial drainage with percutaneous catheter drainage for pericardial effusion. J Invasive Cardiol 24:590–593PubMedPubMedCentral Saltzman AJ, Paz YE, Rene AG et al (2012) Comparison of surgical pericardial drainage with percutaneous catheter drainage for pericardial effusion. J Invasive Cardiol 24:590–593PubMedPubMedCentral
14.
go back to reference Ho MY, Wang JL, Lin YS et al (2015) Pericardiocentesis adverse event risk factors: a nationwide population-based cohort study. Cardiology 130:37–45CrossRefPubMed Ho MY, Wang JL, Lin YS et al (2015) Pericardiocentesis adverse event risk factors: a nationwide population-based cohort study. Cardiology 130:37–45CrossRefPubMed
15.
go back to reference Labbe C, Tremblay L, Lacasse Y (2015) Pericardiocentesis versus pericardiotomy for malignant pericardial effusion: a retrospective comparison. Curr Oncol 22:412–416CrossRefPubMedPubMedCentral Labbe C, Tremblay L, Lacasse Y (2015) Pericardiocentesis versus pericardiotomy for malignant pericardial effusion: a retrospective comparison. Curr Oncol 22:412–416CrossRefPubMedPubMedCentral
Metadata
Title
Pericardial effusion-induced subcutaneous edema in the trunk and lower limbs after percutaneous drainage for carcinomatous pericarditis: report of a case
Authors
Yoichi Nakamura
Junya Tokuhisa
Koji Asai
Toshiyuki Enomoto
Manabu Watanabe
Yoshinari Enomoto
Yoshinori Kikuchi
Yoshihisa Saida
Hideaki Shimada
Shinya Kusachi
Publication date
01-01-2018
Publisher
Springer Japan
Published in
International Cancer Conference Journal / Issue 1/2018
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-017-0310-1

Other articles of this Issue 1/2018

International Cancer Conference Journal 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine